Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

CUSIP: 45782T105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,969,231
Total 13F shares
2,294,234
Share change
-190,138
Total reported value
$19,315,368
Put/Call ratio
86%
Price per share
$8.42
Number of holders
32
Value change
-$2,106,118
Number of buys
11
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q1 2022

As of 31 Mar 2022, Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,294,234 shares. The largest 10 holders included VANGUARD GROUP INC, MORGAN STANLEY, Janney Montgomery Scott LLC, BlackRock Inc., ACT CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, MARSHALL WACE, LLP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and ROYAL BANK OF CANADA. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.